Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9
TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core probiotic strain CP-9 (Bifidobacterium lactis CCTCC M 2014588) has been approved...
Read more